137 related articles for article (PubMed ID: 2115505)
1. Failure of deferoxamine to improve iron overload in chronic hemodialysis patients.
Roxe DM; Krumlovsky FA; Del Greco F; Fitzsimons E
Int J Artif Organs; 1990 Apr; 13(4):211-7. PubMed ID: 2115505
[TBL] [Abstract][Full Text] [Related]
2. [Deferoxamine B treatment of hemosiderosis in the anephric patient undergoing hemodialysis].
Ceriati F; Cavicchioni C; Marino IR; Pomponi M
Chir Patol Sper; 1981 Feb; 29(1):14-9. PubMed ID: 7344858
[No Abstract] [Full Text] [Related]
3. [Iron-overload in patients on maintenance hemodialysis: diagnostic criteria, indications and treatment by desferrioxamine (author's transl)].
Simon P; Bonn F; Guezennec M; Tanquerel T; Ksang
Nephrologie; 1981; 2(4):165-70. PubMed ID: 7329501
[TBL] [Abstract][Full Text] [Related]
4. Correction of haemodialysis-associated anaemia by deferoxamine. Effects on serum aluminum and iron overload.
von Bonsdorff M; Sipilä R; Pitkänen E
Scand J Urol Nephrol Suppl; 1990; 131():49-54. PubMed ID: 2075470
[TBL] [Abstract][Full Text] [Related]
5. Therapy and monitoring of hypersiderosis in chronic renal insufficiency.
Hilfenhaus M; Koch KM; Bechstein PB; Schmidt H; Fassbinder W; Baldamus CA
Contrib Nephrol; 1984; 38():167-74. PubMed ID: 6713893
[TBL] [Abstract][Full Text] [Related]
6. Deferoxamine for the treatment of hemosiderosis during CAPD.
Gomez RA; Campbell F; Savory J; Chevalier RL
Int J Pediatr Nephrol; 1987; 8(1):21-4. PubMed ID: 3583552
[TBL] [Abstract][Full Text] [Related]
7. Iron removal by desferrioxamine in patients on chronic hemodialysis--kinetic study and long-term results.
Kovarik J; Irschik H; Graf H; Woloszczuk W; Meisinger V; Linkesch W; Stummvoll HK
Contrib Nephrol; 1985; 49():44-55. PubMed ID: 3830570
[TBL] [Abstract][Full Text] [Related]
8. Iron overload, but not treatment with desferrioxamine favours the development of septicemia in patients on maintenance hemodialysis.
Seifert A; von Herrath D; Schaefer K
Q J Med; 1987 Dec; 65(248):1015-24. PubMed ID: 3455553
[TBL] [Abstract][Full Text] [Related]
9. Kinetics and efficacy of deferoxamine in iron-overloaded hemodialysis patients.
Stivelman J; Schulman G; Fosburg M; Lazarus JM; Hakim RM
Kidney Int; 1989 Dec; 36(6):1125-32. PubMed ID: 2601259
[TBL] [Abstract][Full Text] [Related]
10. Treatment of iron overload in children and adolescents on chronic haemodialysis.
Eijgenraam FJ; Donckerwolcke RA
Eur J Pediatr; 1990 Feb; 149(5):359-62. PubMed ID: 2311634
[TBL] [Abstract][Full Text] [Related]
11. Management of iron overload in dialysis patients.
Winchester JF
Semin Nephrol; 1986 Dec; 6(4 Suppl 1):22-6. PubMed ID: 3299589
[TBL] [Abstract][Full Text] [Related]
12. Detoxification in hemosiderosis.
Simon P
Blood Purif; 1985; 3(1-3):75-88. PubMed ID: 3913449
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in iron chelation therapy.
Cario H; Janka-Schaub G; Janssen G; Jarisch A; Strauss G; Kohne E
Klin Padiatr; 2007; 219(3):158-65. PubMed ID: 17525910
[TBL] [Abstract][Full Text] [Related]
14. Hemosiderosis in a patient on regular hemodialysis: treatment by desferrioxamine.
Baker LR; Barnett MD; Brozovic B; Cattell WR; Ackrill P; McAlister J; Nimmon C
Clin Nephrol; 1976 Jul; 6(1):326-8. PubMed ID: 954239
[TBL] [Abstract][Full Text] [Related]
15. Hemosiderosis in a dialysis patient: treatment with hemofiltration and deferoxamine chelation therapy.
McCarthy JT; Libertin CR; Mitchell JC; Fairbanks VF
Mayo Clin Proc; 1982 Jul; 57(7):439-41. PubMed ID: 7087549
[TBL] [Abstract][Full Text] [Related]
16. Removal of trace metals by continuous ambulatory peritoneal dialysis after desferrioxamine B chelation therapy.
Navarro JA; Granadillo VA; Rodríguez-Iturbe B; García R; Salgado O; Romero RA
Clin Nephrol; 1991 May; 35(5):213-7. PubMed ID: 1855329
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with desferrioxamine in dialysis patients with aluminium toxicity.
McCarthy JT; Milliner DS; Johnson WJ
Q J Med; 1990 Mar; 74(275):257-76. PubMed ID: 2117295
[TBL] [Abstract][Full Text] [Related]
18. [Infectious risks in patients with renal failure on hemodialysis. Importance of iron overload and deferoxamine].
Hoen B; Kessler M
Presse Med; 1991 Apr; 20(15):681-2. PubMed ID: 1828579
[No Abstract] [Full Text] [Related]
19. Serum bactericidal activity for Yersinia enterocolitica in hemodialysis patients: effects of iron overload and deferoxamine.
Gaughan WJ; Beserab A; Stein HD; Sirota RA; Yudis M
Am J Kidney Dis; 1992 Feb; 19(2):144-8. PubMed ID: 1739096
[TBL] [Abstract][Full Text] [Related]
20. Desferrioxamine in the treatment of aluminum overload.
Ackrill P; Day JP
Clin Nephrol; 1985; 24 Suppl 1():S94-7. PubMed ID: 3842106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
